e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Evolution or revolution in the treatment of asthma and allergies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is antibiotic treatment during asthma exacerbation necessary ?
S. Maazaoui (Tunis, Tunisia)
Source:
International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Session:
Evolution or revolution in the treatment of asthma and allergies
Session type:
Thematic Poster
Number:
4030
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Maazaoui (Tunis, Tunisia). Is antibiotic treatment during asthma exacerbation necessary ?. 4030
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019
Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019
May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001
What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Does long-term macrolide treatment reduce asthma exacerbations? An individual patient data meta-analysis
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis
Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021
Year: 2021
Efficacy of inhaled heparin is effective in the treatment of acute exacerbation of asthma
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007
Systematic review: Does antibiotic treatment duration affect the outcomes of asthma and COPD exacerbations?
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017
Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease?
Source: Annual Congress 2003 - COPD: risk factors and course of disease
Year: 2003
COPD: antibiotic strategy in infectious exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 137s
Year: 2001
Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma?
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
Prudent use of antibiotics: acute exacerbation of COPD as an example
Source: Eur Respir J 2010; 36: 983-985
Year: 2010
Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept